10967/261 - QDB Compounds

QsarDB Repository

Zukić, S.; Osmanović, A.; Harej, A.; Kraljević Pavelić, S.; Špirtović-Halilović, S.; Veljović, E.; Roca, S.; Trifunović, S.; Završnik, D.; Maran, U. Data driven modelling of substituted pyrimidine and uracil-based derivatives validated with newly synthesized and antiproliferative evaluated compounds. Int. J. Mol. Sci. 2024, 25, 9390

Compound

ID:V27
Name:CHEMBL245205
Description:
Labels:Test
CAS:
InChi Code:InChI=1S/C31H30N2O6/c1-2-3-6-15-25-18-24-19-33(31(35)32-29(24)38-25)17-16-26-27(36-20-22-11-7-4-8-12-22)28(30(34)39-26)37-21-23-13-9-5-10-14-23/h4-5,7-14,16,18-19H,2-3,6,15,17,20-21H2,1H3/b26-16-

Properties

pIC50: Antiproliferative activity [-log(uM)] i

ValueSource or prediction
4.77

Gazivoda, T.; Šokčević, M.; Kralj, M.; Šuman, L.; Pavelić, K.; De Clercq, E.; Andrei, G.; Snoeck, R.; Balzarini, J.; Mintas, M.; Raić-Malić, S. Synthesis and Antiviral and Cytostatic Evaluations of the New C-5 Substituted Pyrimidine and Furo[2,3-d]pyrimidine 4‘,5‘-Didehydro-L-ascorbic Acid Derivatives. Journal of Medicinal Chemistry 2007, 50, 4105–4112. http://dx.doi.org/10.1021/jm070324z

4.69262

Eq.1: QSAR model for for antiproliferative activity for HeLa cells (Test set)